3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II

Disease Models & Mechanisms 13(12):dmm045351, 2020

Benefit from our extensive know-how in NASH and test your compound in our validated DIO NASH mouse models.

Kidney

Check out our novel rodent models of diabetic nephropathy.

3D Imaging

Use quantitative light-sheet fluoresence microscopy to validate pre-clinical endpoints.

Obesity

Tap into our vast scientific experience with diet-induced obesity (DIO) models and other commercially available models.

Check out our novel rodent models of cardiovascular disease.

Brain

Check out our capabilities in neurodegenerative diseases.

Diabetes

Qualify and advance your assessment of novel compounds to treat type 2 diabetes and diabetic complications.

Lung (IPF)

Check out our services within lung diseases.